source
- FDA approves AstraZeneca’s baxdrostat for certain patients with hypertensionOne of the key products underpinning AstraZeneca’s goal of hitting $80 billion in revenue by 2030 has been approved by the FDA, the drugmaker said Monday. The blood ...Endpoints · 3mo ago↗ source
- Unlocking more value from mature drug products through strategic outsourcingSee how strategic outsourcing can maximize value and reduce costs for mature drug portfolios.BioPharma Dive · 3mo ago↗ source
- Makary resigns; Biogen reports Alzheimer’s data; and moreWelcome back to Endpoints Weekly. The biggest news this week was Marty Makary’s resignation from his role as FDA Commissioner. The announcement came days after reports emerged that President Donald…Endpoints